Metabolic Disorders
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70

Metabolic Disorders
WCO-IOF 2016: Denosumab versus zoledronic acid following oral bisphosphonate therapy

Shoulder & Elbow
AAOS 2016: Suprascapular/interscalene nerve blocks comparable in rotator cuff repair

Osteoarthritis
Zoledronic acid has no continued benefit beyond 6 years for osteoporosis
J Bone Miner Res. 2015 May;30(5):934-44.

Metabolic Disorders
Discontinuing alendronate after 5 years of treatment, does it affect fracture risk?
JAMA. 2006 Dec 27;296(24):2927-38.

Spine
Annual infusion of zoledronic acid reduces days of back pain, disability, and bed rest
J Bone Miner Res. 2011 May;26(5):984-92. doi: 10.1002/jbmr.292

Spine
Balloon Kyphoplasty Reduces Back Pain in Acute Vertebral Compression Fractures
J Bone Miner Res. 2011 Jul;26(7):1627-37. doi: 10.1002/jbmr.364

Metabolic Disorders
FREEDOM RCT follow-up: Denosumab does not delay fracture healing in osteoporosis patients
J Bone Joint Surg Am. 2012 Oct 24. doi: 10.2106/JBJS.K.00774

General Orthopaedics
The effect of 3 versus 6 years of zoledronic acid treatment on femoral neck-BMD
J Bone Miner Res. 2012 Feb;27(2):243-54. doi: 10.1002/jbmr.1494

Spine
The efficacy of kyphoplasty in the treatment of vertebral compression fractures
Lancet. 2009 Mar 21;373:1016-24. Epub 2009 Feb 24

General Orthopaedics
Denosumab reduces risk of fractures in post-menopausal women
N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.

Metabolic Disorders
Tibolone reduces fracture risk in osteoporotic women but increases stroke risk
N Engl J Med. 2008 Aug 14;359(7):697-708